markets
Abbott Laboratories Shares Down 16% as Analyst Projects 35% Upside
Abbott Laboratories stock has dropped 16% this year, but a market analyst expects the healthcare giant to rebound with potential 35% gains.
Company profile
🇺🇸 United States2 briefsAbbott Laboratories
Global healthcare and medical devices company
AI overview
Global healthcare and medical devices company